These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 88391)
1. Electroimmunoassay of factor IX in patients with liver damage and vitamin K unresponsive coagulation disorder. Girolami A; Burul A; Cappellato G; Dal Bo Zanon R Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(1):65-71. PubMed ID: 88391 [TBL] [Abstract][Full Text] [Related]
2. [Factor IX and factor IX inhibitor]. Higasa S Nihon Rinsho; 2004 Dec; 62 Suppl 12():647-50. PubMed ID: 15658413 [No Abstract] [Full Text] [Related]
3. Laser nephelometer evaluation of factor IX. Ruzza G; Lazzaro AR; Viero ML; Girolami A Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(6):843-9. PubMed ID: 1713891 [TBL] [Abstract][Full Text] [Related]
4. Immune reactive factor IX in acquired factor IX deficiency. Lechner K Thromb Diath Haemorrh; 1972 Feb; 27(1):19-24. PubMed ID: 5033668 [No Abstract] [Full Text] [Related]
5. Congenital bleeding disorders of the vitamin K-dependent clotting factors. Girolami A; Scandellari R; Scapin M; Vettore S Vitam Horm; 2008; 78():281-374. PubMed ID: 18374200 [TBL] [Abstract][Full Text] [Related]
6. Calcium-specific immunoassays for factor IX: reduced levels of antigen in patients with vitamin K disorders. Bray GL; Weinmann AF; Thompson AR J Lab Clin Med; 1986 Mar; 107(3):269-78. PubMed ID: 3485164 [TBL] [Abstract][Full Text] [Related]
7. Coumarin-induced abnormal factor IX: an immunological study in humans. Girolami A; Sticchi A; Burul A Folia Haematol Int Mag Klin Morphol Blutforsch; 1978; 105(1):117-24. PubMed ID: 77812 [TBL] [Abstract][Full Text] [Related]
8. An immunological method for detection of the carrier of hemophilia B. Matsuoka M; Ito M; Takahashi K; Sakuragawa N Thromb Haemost; 1976 Nov; 36(2):441-50. PubMed ID: 1036844 [TBL] [Abstract][Full Text] [Related]
9. Prosthetic heart valves and rare hypersensitivity to vitamin K antagonists resulting from factor IX mutation: how to manage anticoagulation? Holbro A; Marbet GA; Tran TH; Oldenburg J; Friesewinkel O; Tsakiris DA Haemophilia; 2010 Jan; 16(1):187-9. PubMed ID: 19804386 [No Abstract] [Full Text] [Related]
10. Factor IX antigen by radioimmunoassay. Abnormal factor IX protein in patients on warfarin therapy and with hemophilia B. Thompson AR J Clin Invest; 1977 May; 59(5):900-10. PubMed ID: 856873 [TBL] [Abstract][Full Text] [Related]
11. [Clinical significance of factor IX analysis in blood coagulation tests]. Kakishita E; Nishida Y Nihon Rinsho; 1989 Dec; 48 Suppl():834-6. PubMed ID: 2622013 [No Abstract] [Full Text] [Related]
12. Laboratory comparison of the VisuLize IX antigen assay with the Asserachrome IX antigen assay. Janatpour KA; Gosselin RC; Owings JT; Larkin EC Lab Hematol; 2006; 12(3):152-5. PubMed ID: 16950677 [TBL] [Abstract][Full Text] [Related]
13. Factor IX alloantibodies shorten the bovine thromboplastin coagulation time of normal human plasma. Orstavik KH Thromb Haemost; 1981 Dec; 46(4):684-6. PubMed ID: 7330818 [TBL] [Abstract][Full Text] [Related]
14. Factor IX Zutphen. A genetic variant of blood coagulation factor IX with an abnormally high molecular weight. Bertina RM; Van Der Linden IK J Lab Clin Med; 1982 Nov; 100(5):695-704. PubMed ID: 7130828 [TBL] [Abstract][Full Text] [Related]
15. Proceedings: Electroimmunoassay of human coagulation factor IX in the detection of variants of haemophilia B. Orstavik K; Osterud B Thromb Diath Haemorrh; 1975 Sep; 34(1):322-3. PubMed ID: 1188733 [No Abstract] [Full Text] [Related]
16. The liver and blood coagulation: physiology and pathology. Roberts HR; Cederbaum AI Gastroenterology; 1972 Aug; 63(2):297-320. PubMed ID: 4558715 [No Abstract] [Full Text] [Related]
17. [Hemophilia B (factor IX deficiency) with concomitant factor XII degradation in a male crossbreed cat]. Lutze G; Kutschmann K; Fürst K; Schneppenheim R Berl Munch Tierarztl Wochenschr; 2005; 118(5-6):255-60. PubMed ID: 15918491 [TBL] [Abstract][Full Text] [Related]
18. The abnormal factor IX of hemophilia B+ variants. Bertina RM; Veltkamp JJ Thromb Haemost; 1978 Oct; 40(2):335-49. PubMed ID: 734633 [TBL] [Abstract][Full Text] [Related]
19. [Production of various vitamin K-dependent coagulation factors by immunoadsorbent technics and their clinical application]. Takamiya O Rinsho Byori; 1985 Feb; Spec No 61():119-23. PubMed ID: 3889420 [No Abstract] [Full Text] [Related]
20. Haemophilia B Leyden in Greece. Mandalaki T; Louizou C; Dimitriadou C; Briët E Thromb Haemost; 1986 Dec; 56(3):340-2. PubMed ID: 3563965 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]